Olympus Launches iTind™ Center of Excellence Program to Advance Care for Men with Enlarged Prostate

12 September 2025 | Friday | News

The inaugural program recognises leading urologists trained and experienced in the iTind procedure, underscoring Olympus’ commitment to improving outcomes and quality of life for patients with benign prostatic hyperplasia (BPH).

Olympus Corp. of the Americas is proud to announce the new iTind™ Center of Excellence (COE) Program, which is designed to enhance care, experience and outcomes for men suffering from symptoms associated with benign prostatic hyperplasia (BPH), known as enlarged prostate.

In its inaugural year, the iTind Center of Excellence Program welcomes three members: C. Cragin Anderson, MD, FACS, a board-certified urologist with Colorado Urology; Petar Bajic, MD, a board-certified urologist and Director of Men's Health at Glickman Urological Institute, Cleveland Clinic; and Alex M. Kandabarow, MD, a board-certified urologist with Virginia Hospital Center Health Urology – Kingstowne.

"We are thrilled to welcome these inaugural members to the iTind Center of Excellence Program," said Matt Woodward, Vice President and Regional Business Lead for Urology at Olympus. "Patients suffering from enlarged prostate need to know that there are safe and effective alternatives to medications and invasive surgeries for relieving urinary symptoms that can seriously affect their quality of life. Our relationship with these physicians is centered on excellence in patient care and experience and aimed towards improving patient outcomes in BPH treatment."

Benchmarks for achieving an iTind Center of Excellence status for a urologist treating patients with the iTind procedure include, but are not limited to:

  • Completing a specialized iTind training program;
  • Upholding clinical proficiency by performing a minimum number of cases annually; and
  • Providing de-identified patient data showing a mean improvement score based on FDA guidance for BPH treatments.

 

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close